Physician profile
James Penna
NPI 1710928957
$900.94
in general payments reported to CMS, 2019-2025
11 companies · $250 in 2025
The $250 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $27.03 · 2021: $45.57 · 2022: $68.30 · 2023: $407 · 2024: $103 · 2025: $250.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $760.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $760.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $255.38 | 2021-2025 | Euflexxa |
| Stryker Corporation | $143.35 | 2023 | Mako |
| Depuy Synthes Sales INC. | $105.79 | 2023-2025 | Viper, Symphony, Fibergraft Bg Morsels |
| Zimmer Biomet Holdings, INC. | $105.65 | 2025 | Rosa |
| Boston Scientific Corporation | $76.01 | 2024-2025 | Intracept |
| Djo, LLC | $56.12 | 2023 | Cmf |
| Horizon Therapeutics Plc | $47.89 | 2019-2022 | |
| Relievant Medsystems, INC. | $47.44 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $43.02 | 2023 | Zilretta, Iovera |
| Medtronic, INC. | $20.29 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Penna listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.